Skip to content

Coronary Artery Bypass Grafting: Factors Related to Late Events and Saphenous Graft Patency

Coronary Artery Bypass Grafting: Factors Related to Late Events and Saphenous Graft Patency

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00755248
Enrollment
300
Registered
2008-09-18
Start date
2007-01-31
Completion date
2011-01-31
Last updated
2008-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Myocardial Revascularization

Keywords

Coronary Artery Bypass Grafting (CABG), outcome, saphenous graft patency, biochemical factors, genomics

Brief summary

The purpose of this study is to determine the relations between conventional and unconventional risk factors and adverse clinical events at follow-up (including coronary bypass patency) in patients undergoing surgical myocardial revascularization.

Detailed description

Coronary artery bypass grafting represents one of the most frequent surgical procedure performed in the United States and Europe. The clinical benefit of myocardial revascularization is related to freedom of adverse cardiovascular events and to graft patency, above all of great saphenous vein, which is nowadays the main autologous vessel used for grafting coronaries different from anterior interventricular artery. Unfortunately, phenomena leading to early and, above all, late complications and to graft occlusion are not fully clarified and it so not possible to explain interindividual and temporary variability of progressive stenosis rate only on the basis of classical atherosclerosis risk factors. The aim of our study is to prospectively study the role of conventional risk factors (preoperative risk factors and clinical features) and of unconventional risk factors (genetic polymorphisms, inflammation and coagulation markers) with saphenous late patency and postoperative patients outcome, in particular with regard to adverse clinical events (myocardial infarction, successive stenting procedures, arrhythmias etc.)and to bypass patency. Plasma venous samples will be collected the day before surgery, at discharge from the hospital, and at follow-up from patients undergoing on-pump and off-pump coronary artery bypass grafting and stored at -80°C; Patients will be followed-up periodically with visits and telephone interviews, and will be also invited to undergo multislice (64 rows) CT scan in order to assess graft patency between 12 and 24 months after surgery. Finally the relation between conventional and unconventional risk factors with adverse events at follow-up will be assessed with multivariable statistical models.

Interventions

PROCEDURECoronary Artery Bypass Grafting

Coronary Artery Bypass Grafting on- or off-pump

Sponsors

Centro Cardiologico Monzino
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Men and women age 18 to 89 * Elective primary CABG * Female patients must be non-lactating and not pregnant * Able and willing to comply with study requirements by signing a consent form

Exclusion criteria

* Concomitant surgery * Major end organ dysfunction * Serious intercurrent illness or infection * Known coagulation disorders * Emergencies

Countries

Italy

Contacts

Primary ContactAlessandro Parolari, MD, PhD
alessandro.parolari@ccfm.it00390258002558

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026